Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

KEMET Prices $110 Mln Of Senior Notes

RELATED NEWS
Trade KEM now with 

KEMET Corp. (KEM: Quote) said Thursday that it has priced an offering of $110 million of aggregate principal amount of 10-1/2% senior notes due 2018.

This represents an increase of $10 million from the initial offering terms announced earlier Thursday. The Senior Notes are priced at 105.5% on a principal amount of $110 million plus accrued interest from November 1, 2011.

The sale of the senior notes is expected to be completed on or about March 27.

KEMET plans to use the net proceeds from the sale of the senior notes to finance a portion of the acquisition of Niotan Inc., make the initial payment to acquire a portion of NEC TOKIN Corp., pay related transactions fees and expenses and for general corporate purposes.

Click here to receive FREE breaking news email alerts for KEMET Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.